CF
ABBV icon

Concorde Financial’s AbbVie ABBV Stock Holding History

Concorde Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.91M Sell
27,153
-4,059
-13% -$900K 4.64% 10
2025
Q4 		$7.04M Sell
31,212
-577
-2% -$131K 5.46% 5
2025
Q3 		$7.36M Sell
31,789
-916
-3% -$187K 4.08% 6
2025
Q2 		$6.07M Sell
32,705
-94
-0.3% -$17.5K 3.59% 11
2025
Q1 		$6.87M Sell
32,799
-98
-0.3% -$19.1K 3.79% 8
2024
Q4 		$5.85M Buy
32,897
+124
+0.4% +$22.8K 3.48% 10
2024
Q3 		$6.47M Sell
32,773
-420
-1% -$78.4K 3.81% 7
2024
Q2 		$5.69M Sell
33,193
-8,225
-20% -$1.36M 3.74% 9
2024
Q1 		$7.54M Sell
41,418
-70
-0.2% -$12.1K 6.86% 3
2023
Q4 		$6.43M Buy
41,488
+34,788
+519% +$5.07M 4.4% 5
2023
Q3 		$999K Sell
6,700
-34,038
-84% -$5M 1.7% 12
2023
Q2 		$5.49M Sell
40,738
-570
-1% -$83.6K 3.59% 9
2023
Q1 		$6.58M Sell
41,308
-581
-1% -$88.8K 4.8% 4
2022
Q4 		$5.62M Hold
41,889
– – 3.79% 6
2022
Q3 		$5.62M Sell
41,889
-81
-0.2% -$11.6K 3.79% 6
2022
Q2 		$6.43M Sell
41,970
-3,585
-8% -$548K 7.18% 3
2022
Q1 		$6.78M Sell
45,555
-1,282
-3% -$186K 4.17% 6
2021
Q4 		$6.33M Buy
+46,837
New +$5.53M 3.98% 5

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Concorde Financial's ABBV Position: Q1 2026 in Review

Concorde Financial reduced its AbbVie (ABBV) stake by 13% in Q1 2026, selling an estimated $900K and leaving 27,153 shares worth $5.91M. The position accounts for 4.64% of the portfolio, ranked #10.

Concorde Financial first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $7.54M in Q1 2024. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Concorde Financial held 27,153 shares of AbbVie worth $5.91M as of Q1 2026.
  • Concorde Financial sold 4,059 AbbVie shares in Q1 2026, an estimated $900K.
  • AbbVie made up 4.64% of Concorde Financial's portfolio in Q1 2026, its #10 holding.
  • Concorde Financial first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • Concorde Financial's AbbVie position peaked at $7.54M in Q1 2024.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Concorde Financial's 13F filing for Q1 2026, filed 15 May 2026.